treatment
Menarini Group and Insilico Medicine enter into exclusive global license agreement for new KAT6 inhibitor for potential treatment of breast cancer and other oncology indications USA – Deutsch Italia – Italiano APAC – Traditional Chinese USA – español Latin America – español USA – English USA – English
KAT6 is a new target in hormone-sensitive breast cancer tumors and other cancers. Overexpression of KAT6A/B is associated with poor clinical outcomes in patients with ER+/HER2- breast cancer, one of the most common subtypes. The molecule showed high preclinical activity. Insilico presented data on this new molecule at the San Antonio Breast Cancer Symposium in […]
Clear superiority of cold plasma therapy in the treatment of chronic wounds
Share on: 09/19/2023 23:27 Clear superiority of cold plasma therapy in the treatment of chronic wounds The Journal of Clinical Medicine (MDPI) has published the interim results of the clinical study “POWER” (“Plasma on chronic Wounds for Epidermal Regeneration”). The randomized, controlled, multicenter clinical study examined the effectiveness of a new form of therapy (cold […]
AI in personalized medicine: Better risk detection, prevention and treatment of carotid stenosis | TAXINOMISIS Project | Results in brief | H2020 | CORDIS
By using artificial intelligence (AI), researchers have developed a novel disease mechanism-based stratification for people with carotid stenosis, enabling tailored therapeutic interventions. Health © TAXINOMISIS Carotid stenosis is caused by the narrowing or blockage of the carotid artery due to plaque buildup (atherosclerosis). Current screening for asymptomatic carotid stenosis, stroke prevention and disease management are […]